EIF4A3 and acute myeloid leukemia: In conclusion, our data suggest that AML cells are dependent on eIF4A3 and feature aberrant post-transcriptional gene regulation (affecting ribosome biogenesis and other processes), a vulnerability that could be exploited in AML therapy.